Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5 AND LACTATED RINGER S IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5 AND LACTATED RINGER S IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the major intracellular cation; it maintains intracellular tonicity, is essential for nerve impulse transmission, cardiac contraction, and skeletal muscle function. Dextrose provides metabolic energy. Lactated Ringer's solution replaces extracellular fluid and electrolytes.
Potassium chloride dissociates to potassium ions, which are essential for maintaining intracellular tonicity, nerve impulse conduction, muscle contraction, and acid-base balance. Replacement therapy corrects hypokalemia and prevents potassium deficiency.
Adult: 10-20 mEq/h IV, not exceeding 30 mEq/h or 200 mEq/day; rate determined by serum potassium and ECG monitoring. Maximum concentration 40 mEq/L in peripheral line, 100 mEq/L in central line.
10-20 mEq/h IV, not exceeding 20 mEq/h; concentration ≤ 0.2 mEq/mL. Typical total daily dose 40-100 mEq, depending on serum potassium.
None Documented
None Documented
Not applicable; potassium is an electrolyte with no classical half-life. Serum potassium regulation depends on redistribution (t1/2 ~1-2 hours) and renal excretion (rate varies with GFR).
Not applicable (endogenous ion); distribution half-life ~1-1.5 h with normal renal function.
Renal: >90% as potassium ions; minimal biliary/fecal elimination.
Renal: >90% as potassium ions, with small fecal loss; no biliary elimination.
Category C
Category C
Electrolyte Replenisher
Electrolyte Replenisher